Metastasin S100A4 is a mediator of sex hormone-dependent formation of the cortical bone

Molecular Endocrinology

Volumn 27, Issue 8, 2013, Pages 1311-1321

  Erlandsson, Malin C ^a   Bian, Li ^a   Jonsson, Ing Marie ^a   Andersson, Karin M ^a   Bokarewa, Maria I ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CALVASCULIN; CATHEPSIN K; ESTROGEN; LENTIVIRUS VECTOR; OSTEOCALCIN; PRASTERONE; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; SEX HORMONE; SHORT HAIRPIN RNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE STRENGTH; BONE STRUCTURE; BONE TURNOVER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORTICAL BONE; FEMALE; HORMONAL REGULATION; IMMUNOHISTOCHEMISTRY; MOUSE; MUSCULOSKELETAL SYSTEM PARAMETERS; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; OVARIECTOMY; PERIOSTEUM; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; TRABECULAR BONE; TRANSCRIPTION REGULATION; WILD TYPE;

ANIMALS; BONE DENSITY; BONE RESORPTION; DEHYDROEPIANDROSTERONE; ESTROGENS; FEMALE; FEMUR; MICE; MICE, KNOCKOUT; OSTEOBLASTS; OSTEOCALCIN; OSTEOCLASTS; OSTEOGENESIS; OVARIECTOMY; RNA INTERFERENCE; RNA, SMALL INTERFERING; S100 PROTEINS;

EID: 84880767065     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2012-1398     Document Type: Article

References (47)

1. Krum SA. Direct transcriptional targets of sex steroid hormones in bone. J Cell Biochem. 2011;112:401-408.
2. Callewaert F, Sinnesael M, Gielen E, Boonen S, Vanderschueren D. Skeletal sexual dimorphism: relative contribution of sex steroids, GH-IGF1, and mechanical loading. J Endocrinol. 2010;207:127-134.
3. Frank GR. Role of estrogen and androgen in pubertal skeletal physiology. Med Pediatr Oncol. 2003;41:217-221.
4. Riggs BL, Khosla S, Melton LJ 3rd. Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev. 2002;23: 279-302.
5. Vanderschueren D, Vandenput L, Boonen S, Lindberg MK, Bouillon R, Ohlsson C. Androgens and bone. Endocr Rev. 2004;25:389-425.
6. Khosla S, Atkinson EJ, Dunstan CR, O'Fallon WM. Effect of estrogen versus testosterone on circulating osteoprotegerin and other cytokine levels in normal elderly men. J Clin Endocrinol Metab. 2002;87:1550-1554.
7. Windahl SH, Lagerquist MK, Andersson N, et al. Identification of target cells for the genomic effects of estrogens in bone. Endocrinology. 2007;148:5688-5695.
8. Denger S, Bahr-Ivacevic T, Brand H, et al. Transcriptome profiling of estrogen-regulated genes in human primary osteoblasts reveals an osteoblast-specific regulation of the insulin-like growth factor binding protein 4 gene. Mol Endocrinol. 2008;22:361-379.
9. Almeida M, Iyer S, Martin-Millan M, et al. Estrogen receptor-α signaling in osteoblast progenitors stimulates cortical bone accrual. J Clin Invest. 2013;123:394-404.
10. Syed FA, Fraser DG, Monroe DG, Khosla S. Distinct effects of loss of classical estrogen receptor signaling versus complete deletion of estrogen receptor α on bone. Bone. 2011;49:208-216.
11. Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature. 2003;423:337-342.
12. Cheung J, Mak YT, Papaioannou S, Evans BA, Fogelman I, Hampson G. Interleukin-6 (IL-6), IL-1, receptor activator of nuclear factor κB ligand (RANKL) and osteoprotegerin production by human osteoblastic cells: comparison of the effects of 17-β oestradiol and raloxifene. J Endocrinol. 2003;177:423-433.
13. Bord S, Ireland DC, Beavan SR, Compston JE. The effects of estrogen on osteoprotegerin, RANKL, and estrogen receptor expression in human osteoblasts. Bone. 2003;32:136-141.
14. Mazzucchelli L. Protein S100A4: too long overlooked by pathologists? Am J Pathol. 2002;160:7-13.
15. Boye K, Maelandsmo GM. S100A4 and metastasis: a small actor playing many roles. Am J Pathol. 2010;176:528-535.
16. Grigorian M, Andresen S, Tulchinsky E, et al. Tumor suppressor p53 protein is a new target for the metastasis-associated Mts1/ S100A4 protein: functional consequences of their interaction. J Biol Chem. 2001;276:22699-22708.
17. Li X, Baskin JG, Mangan EK, et al. The unique cytoplasmic domain of human Fc_RIIIA regulates receptor-mediated function. J Immunol. 2012;189:4284-4294.
18. Duarte WR, Shibata T, Takenaga K, et al. S100A4: a novel negative regulator of mineralization and osteoblast differentiation. J Bone Miner Res. 2003;18:493-501.
19. Kato C, Kojima T, Komaki M, et al. S100A4 inhibition by RNAi up-regulates osteoblast related genes in periodontal ligament cells. Biochem Biophys Res Commun. 2005;326:147-153.
20. de Silva Rudland S, Martin L, Roshanlall C, et al. Association of S100A4 and osteopontin with specific prognostic factors and survival of patients with minimally invasive breast cancer. Clin Cancer Res. 2006;12:1192-1200.
21. Bjornland K, Winberg JO, Odegaard OT, et al. S100A4 involvement in metastasis: deregulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in osteosarcoma cells transfected with an anti-S100A4 ribozyme. Cancer Res. 1999;59: 4702-4708.
22. Saleem M, Kweon MH, Johnson JJ, et al. S100A4 accelerates tumorigenesis and invasion of human prostate cancer through the transcriptional regulation of matrix metalloproteinase 9. Proc Natl Acad Sci USA. 2006;103:14825-14830.
23. Elenjord R, Ljones H, Sundkvist E, Loennechen T, Winberg JO. Dysregulation of matrix metalloproteinases and their tissue inhibitors by S100A4. Connect Tissue Res. 2008;49:185-188.
24. Senolt L, Grigorian M, Lukanidin E, Simmen B, et al. S100A4 is expressed at site of invasion in rheumatoid arthritis synovium and modulates production of matrix metalloproteinases. Ann Rheum Dis. 2006;65:1645-1648.
25. Naaman CEL, Grum-Schwensen B, Mansouri A, et al. Cancer predisposition in mice deficient for the metastasis-associated Mts1(S100A4) gene. Oncogene. 2004;23:3670-3680.
26. Du C, Khalil MW, Sriram S. Administration of dehydroepiandrosterone suppresses experimental allergic encephalomyelitis in SJL/J mice. J Immunol. 2001;167:7094-7101.
27. de Hooge AS, van de Loo FA, Bennink MB, et al. Adenoviral transfer of murine oncostatinMelicits periosteal bone apposition in knee joints of mice, despite synovial inflammation and up-regulated expression of interleukin-6 and receptor activator of nuclear factor- κB ligand. Am J Pathol. 2002;160:1733-1743.
28. Windahl SH, Vidal O, Andersson G, Gustafsson JA, Ohlsson C. Increased cortical bone mineral content but unchanged trabecular bone mineral density in female ERβ(-/-) mice. J Clin Invest. 1999; 104:895-901.
29. Jamsa T, Jalovaara P, Peng Z, Vaananen HK, Tuukkanen J. Comparison of three-point bending test and peripheral quantitative computed tomography analysis in the evaluation of the strength of mouse femur and tibia. Bone. 1998;23:155-161.
30. Callewaert F, Venken K, Kopchick JJ, et al. Sexual dimorphism in cortical bone size and strength but not density is determined by independent and time-specific actions of sex steroids and IGF-1: evidence from pubertal mouse models. J Bone Miner Res. 2010;25: 617-626.
31. Ford HL, Silver DL, Kachar B, Sellers JR, Zain SB. Effect of Mts1 on the structure and activity of nonmuscle myosin II. Biochemistry. 1997;36:16321-16327.
32. Li ZH, Spektor A, Varlamova O, Bresnick AR. Mts1 regulates the assembly of nonmuscle myosin-IIA. Biochemistry. 2003;42: 14258-14266.
33. Elliott PR, Irvine AF, Jung HS, et al. Asymmetric mode of Ca(2)(-)- S100A4 interaction with nonmuscle myosin IIA generates nanomolar affinity required for filament remodeling. Structure. 2012;20: 654-666.
34. Gorodeski GI. Estrogen modulation of MgATPase activity of nonmuscle myosin-II-B filaments. Endocrinology. 2007;148:279-292.
35. Kramar EA, Babayan AH, C MG, Lynch G. Estrogen promotes learning related plasticity by modifying the synaptic cytoskeleton. Neuroscience. 2013;239:3-16.
36. Mendelsohn ME, Karas RH. Rapid progress for non-nuclear estrogen receptor signaling. J Clin Invest. 2010;120:2277-2279.
37. Stein U, Arlt F, Walther W, et al. The metastasis-associated gene S100A4 is a novel target ofβ-catenin/T-cell factor signaling in colon cancer. Gastroenterology. 2006;131:1486-1500.
38. Berge G, Pettersen S, Grotterod I, Bettum IJ, Boye K, Maelandsmo GM. Osteopontin-an important downstream effector of S100A4- mediated invasion and metastasis. Int J Cancer. 2011;129:780-790.
39. Sjogren K, Bohlooly YM, Olsson B, et al. Disproportional skeletal growth and markedly decreased bone mineral content in growth hormone receptor-/- mice. Biochem Biophys Res Commun. 2000;267:603-608.
40. MacLean HE, Moore AJ, Sastra SA, et al. DNA-binding-dependent androgen receptor signaling contributes to gender differences and has physiological actions in males and females. J Endocrinol. 2010; 206:93-103.
41. Venken K, De Gendt K, Boonen S, et al. Relative impact of androgen and estrogen receptor activation in the effects of androgens on trabecular and cortical bone in growing male mice: a study in the androgen receptor knockout mouse model. J Bone Miner Res. 2006;21:576-585.
42. Wang L, Wang YD, Wang WJ, Zhu Y, Li DJ. Dehydroepiandrosterone improves murine osteoblast growth and bone tissue morphometry via mitogen-activated protein kinase signaling pathway independent of either androgen receptor or estrogen receptor. J Mol Endocrinol. 2007;38:467-479.
43. Takayanagi R, Goto K, Suzuki S, Tanaka S, Shimoda S, Nawata H. Dehydroepiandrosterone (DHEA) as a possible source for estrogen formation in bone cells: correlation between bone mineral density and serum DHEA-sulfate concentration in postmenopausal women, and the presence of aromatase to be enhanced by 1,25- dihydroxyvitamin D3 in human osteoblasts. Mech Ageing Dev. 2002;123:1107-1114.
44. Villareal DT, Holloszy JO, Kohrt WM. Effects of DHEA replacement on bone mineral density and body composition in elderly women and men. Clin Endocrinol (Oxf). 2000;53:561-568.
45. Nair KS, Rizza RA, O'Brien P, et al. DHEA in elderly women and DHEA or testosterone in elderly men. N Engl J Med. 2006;355: 1647-1659.
46. Wang L, Wang YD, Wang WJ, Li DJ. Differential regulation of dehydroepiandrosterone and estrogen on bone and uterus in ovariectomized mice. Osteoporosis Int. 2009;20:79-92.
47. Konduri SD, Medisetty R, Liu W, et al. Mechanisms of estrogen receptor antagonism toward p53 and its implications in breast cancer therapeutic response and stem cell regulation. Proc Natl Acad Sci USA. 2010;107:15081-15086.